These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 24319154)

  • 1. Iron and hepcidin: a story of recycling and balance.
    Camaschella C
    Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
    Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
    Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of iron overload disorders and iron-linked anemias.
    Kaplan J; Ward DM; De Domenico I
    Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic iron homeostasis and erythropoiesis.
    Papanikolaou G; Pantopoulos K
    IUBMB Life; 2017 Jun; 69(6):399-413. PubMed ID: 28387022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron metabolism and iron disorders revisited in the hepcidin era.
    Camaschella C; Nai A; Silvestri L
    Haematologica; 2020; 105(2):260-272. PubMed ID: 31949017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?
    Rausa M; Pagani A; Nai A; Campanella A; Gilberti ME; Apostoli P; Camaschella C; Silvestri L
    PLoS One; 2015; 10(4):e0122696. PubMed ID: 25860887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the Iron Homeostatic Hormone Hepcidin.
    Sangkhae V; Nemeth E
    Adv Nutr; 2017 Jan; 8(1):126-136. PubMed ID: 28096133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Homeostasis in Health and Disease.
    Gozzelino R; Arosio P
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin and iron homeostasis.
    Ganz T; Nemeth E
    Biochim Biophys Acta; 2012 Sep; 1823(9):1434-43. PubMed ID: 22306005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.
    Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C
    Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of hepcidin and iron-overload disease.
    Lee PL; Beutler E
    Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
    Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
    Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
    Xu Y; Alfaro-Magallanes VM; Babitt JL
    Br J Haematol; 2021 Jun; 193(5):882-893. PubMed ID: 33316086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.
    Nai A; Pellegrino RM; Rausa M; Pagani A; Boero M; Silvestri L; Saglio G; Roetto A; Camaschella C
    Haematologica; 2014 Jun; 99(6):1016-21. PubMed ID: 24658816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.
    Ganz T; Nemeth E; Rivella S; Goldberg P; Dibble AR; McCaleb ML; Guo S; Monia BP; Barrett TD
    Adv Ther; 2023 Apr; 40(4):1317-1333. PubMed ID: 36690839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.
    Vadolas J; Ng GZ; Kysenius K; Crouch PJ; Dames S; Eisermann M; Nualkaew T; Vilcassim S; Schaeper U; Grigoriadis G
    Br J Haematol; 2021 Jul; 194(1):200-210. PubMed ID: 33942901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.